Bizily Scott's Form 4 filing
4D Molecular Therapeutics, Inc. (FDMT) · filed Apr 3, 2024
- Accession no.
- 0000950170-24-041418
- Filed
- Apr 3, 2024
- Trade date
- Apr 1, 2024
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Checked
This filing lists 5 non-derivative transactions and 4 derivative transactions. Open-market sales total $259.1K. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Bizily ScottCIK 0001920738 | Officer (Chief Legal Officer) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Apr 1, 2024 | Common Stock | MOption exerciseAcquired | +1,332 | $6.49 | +$8,644.68 | 3,069 | Direct | |
| Apr 1, 2024 | Common Stock | MOption exerciseAcquired | +2,916 | $8.04 | +$23,444.64 | 5,985 | Direct | |
| Apr 1, 2024 | Common Stock | MOption exerciseAcquired | +1,996 | $15.78 | +$31,496.88 | 7,981 | Direct | |
| Apr 1, 2024 | Common Stock | MOption exerciseAcquired | +1,909 | $20.24 | +$38,638.16 | 9,890 | Direct | |
| Apr 1, 2024 | Common Stock | SSaleDisposed | −8,153 | $31.78 | −$259,102.34 | 1,737 | Direct |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Apr 1, 2024 | Common Stock | MOption exerciseDisposed | −1,332 | $0.00 | $0 | 14,711 | Direct | |
| Apr 1, 2024 | Common Stock | MOption exerciseDisposed | −2,916 | $0.00 | $0 | 40,418 | Direct | |
| Apr 1, 2024 | Common Stock | MOption exerciseDisposed | −1,996 | $0.00 | $0 | 21,008 | Direct | |
| Apr 1, 2024 | Common Stock | MOption exerciseDisposed | −1,909 | $0.00 | $0 | 46,182 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.